Sarcopenic obesity is associated with telomere shortening: findings from the NHANES 1999-2002.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
02 2022
Historique:
received: 04 07 2021
accepted: 11 10 2021
revised: 29 09 2021
pubmed: 6 11 2021
medline: 19 2 2022
entrez: 5 11 2021
Statut: ppublish

Résumé

Sarcopenic obesity (SO) is characterised by the concurrent presence of sarcopenia and excess adiposity. Telomere shortening has been associated with sarcopenia and obesity alone but the association between SO and telomere length (TL) has not been investigated. This study aimed to investigate SO and TL in an adult population. Data were from 5397 individuals (mean age = 44.7 years, 51.3% male) enrolled in the National Health and Nutrition Examination Survey. Body composition (BC) was assessed by Dual Energy X-Ray Absorptiometry. Two models were used to assess SO: a BC model including four phenotypes derived from the combination of high or low adiposity and muscle mass; and, a truncal fat mass to appendicular skeletal mass ratio (TrFM/ASM). TL was assessed using quantitative polymerase chain reaction and expressed as base pairs. The mean TL, relative to the reference DNA, was calculated and expressed as the mean T/S ratio. A General Linear Model was applied to determine associations between TL for SO. In adjusted analysis, only individuals with SO, defined as the presence of high adiposity-low muscle mass (four-phenotype model), had significantly shorter telomeres (p = 0.05) than the reference group (i.e. low adiposity-high muscle mass), with a mean T/S ratio of 1.02 (95%CI: 0.98-1.05) compared to 1.05 (95%CI: 1.01-1.09), respectively. TrFM/ASM was not associated with TL. Preliminary findings suggest that sarcopenia and obesity may act synergistically to shorten telomeres.

Identifiants

pubmed: 34737398
doi: 10.1038/s41366-021-00995-z
pii: 10.1038/s41366-021-00995-z
pmc: PMC8794780
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-440

Informations de copyright

© 2021. The Author(s).

Références

Am J Clin Nutr. 2014 Jun;99(6):1369-77
pubmed: 24760978
Clin Nutr. 2016 Dec;35(6):1472-1483
pubmed: 27091774
Front Endocrinol (Lausanne). 2020 May 21;11:332
pubmed: 32508753
Clin Nutr. 2018 Dec;37(6 Pt A):1787-1793
pubmed: 29857921
Public Health Nutr. 2015 May;18(7):1245-54
pubmed: 25221994
Diabetes Obes Metab. 2018 Jan;20(1):141-147
pubmed: 28671751
J Appl Physiol (1985). 2007 Mar;102(3):919-25
pubmed: 17095641
Vital Health Stat 1. 2013 Aug;(56):1-37
pubmed: 25078429
Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):28-34
pubmed: 21102320
Am J Clin Nutr. 2018 Sep 1;108(3):453-475
pubmed: 30535086
Nature. 2011 Feb 17;470(7334):359-65
pubmed: 21307849
Biogerontology. 2018 Jul;19(3-4):209-221
pubmed: 29549539
Ann N Y Acad Sci. 2004 Jun;1019:278-84
pubmed: 15247029

Auteurs

Thomas Goddard (T)

School of Life Sciences, Division of Physiology, Pharmacology and Neuroscience, University of Nottingham, Queen's Medical Centre, Nottingham, UK.

Kostas Tsintzas (K)

School of Life Sciences, Division of Physiology, Pharmacology and Neuroscience, University of Nottingham, Queen's Medical Centre, Nottingham, UK.

Blossom C M Stephan (BCM)

Institute of Mental Health, The University of Nottingham Medical School, Nottingham, UK.

Carla M Prado (CM)

Human Nutrition Research Unit, Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.

Mohsen Mazidi (M)

Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.

Mario Siervo (M)

School of Life Sciences, Division of Physiology, Pharmacology and Neuroscience, University of Nottingham, Queen's Medical Centre, Nottingham, UK. mario.siervo@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH